Bring the Amgen FIRST STEP™ Program to your office

Help all eligible patients* obtain coverage for their deductibles,
co-payments, and/or co-insurance: it’s as simple as CARD

Call
to register your practice
Make one-time call to the Register Terminal:
  • Call 1-888-65-STEP1
  • Submit your merchant ID for the credit card terminal your office will use to swipe Amgen FIRST STEP™ Co-pay Coupon Cards
Assess
patients for
potential eligibility
For patients prescribed to an eligible Amgen product, identify patients prior to treatment initiation - Patient eligibility requirements*:
  • Patient must be prescribed Neulasta® (pegfilgrastim), Neulasta® Onpro®, NEUPOGEN® (filgrastim), Nplate® (romiplostim), XGEVA® (denosumab), Prolia® (denosumab), Vectibix® (panitumumab), IMLYGIC® (talimogene laherparepvec) KYPROLIS® (carfilzomib), or BLINCYTO® (blinatumomab)
  • Must have private commercial health insurance that covers medication costs for Neulasta®, Neulasta® Onpro(R), NEUPOGEN®, Nplate®, XGEVA®, Prolia®, Vectibix®, IMLYGIC®, KYPROLIS®, or BLINCYTO®
  • Must not be a participant in any federal-, state-, or government-funded healthcare program such as Medicare, Medicare Advantage, Medicare Part D, Medicaid, Medigap, Veterans Affairs (VA), the Department of Defense (DoD), or TriCare
  • May not seek reimbursement for value received from the Amgen FIRST STEPTM Program from any third-party payers, including flexible spending accounts or healthcare savings accounts. If at any time patients begin receiving coverage under any federal-, state-, or government- funded healthcare program, patients will no longer be eligible to participate in the Amgen FIRST STEP Program and must call 1-888-65-STEP1 (1-888- 657-8371) Monday through Friday, 9 AM-8 PM EST to stop participation. Restrictions may apply. This is not health insurance. Program invalid where otherwise prohibited by law.
Register
patients for
program
Assist patients with required forms, available at AmgenFIRSTSTEP.com:
1. Enrollment form, with eligibility questions
  • Help patients complete and submit
  • Remember that the patient must be the one completing or reviewing and confirming eligibility questions themselves
2. Privacy Notice and Patient Authorization form
  • Submit signed Privacy Notice and Patient Authorization form online or by fax (click on “Prefer to fax” button online and follow instructions)
3. Register before any treatment. (See cover for eligible Amgen products.) Upon approval, card will be activated.
Deliver
savings to your
eligible patient
Swipe patient’s card to collect deductible, co-insurance, or co-payment for one dose of the Amgen product
  • First swipe: OOP cost share = $0
  • Subsequent swipe: OOP cost share = $5 (except for Prolia®, which is $25)
To submit Explanation of Benefits (EOB) and other relevant documentation, please fax 1-888-653-2972 or mail to:
 The Macaluso Group
 at 100 Passaic Avenue, Suite 245
 Fairfield, NJ 07004 -
 ATTN: Amgen FIRST STEP® Program.
Submit EOB within 45 days of initial swipe
Contact the Amgen FIRST STEP™ Co-Pay Coupon Card Program for complete program details
PHONE: 1-888-65-STEP1/ (1-888-657-8371)
Monday–Friday, 9:00 AM–8:00 PM ET
WEBSITE: AmgenFIRSTSTEP.com
FAX: 1-888-653-2972

Coverage Limits/Program Maximums:

  • Program covers out-of-pocket medication costs for the Amgen product only. Program does not cover any other costs related to office visit or administration of the Amgen product.
  • For Neulasta®, Neulasta® Onpro®, NEUPOGEN®, Nplate®, XGEVA®, Vectibix®, IMLYGIC®, and BLINCYTO®: no out-of-pocket cost for first dose or cycle; $5 out-of-pocket cost for subsequent dose or cycle; maximum benefit of $10,000 per patient per calendar year. Patient is responsible for costs above these amounts.
  • For KYPROLIS®: no out-of-pocket cost for first dose or cycle; $5 out-of- pocket cost for subsequent dose or cycle; maximum benefit of $20,000 per patient per calendar year. Patient is responsible for costs above these amounts.
  • For Prolia®: no out-of-pocket cost for first dose or cycle; $25 out-of-pocket cost for subsequent dose or cycle; maximum benefit of $1,500 per patient per calendar year. Patient is responsible for costs above these amounts.
  • Ongoing activation of the Amgen FIRST STEP card is contingent on the submission of the required Explanation of Benefits (EOB) form by the healthcare provider's office within 45 days of use of the Amgen FIRST STEP card. Patients will be responsible for reimbursing the program for all amounts paid out if the EOB for the date of service is not received within 45 days.